{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:10:31Z","timestamp":1770063031652,"version":"3.49.0"},"reference-count":183,"publisher":"American Physiological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Renal Physiology"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:p>We have recently proposed severe cardiorenal syndrome (SCRS), in which cardiac and renal failure mutually amplify progressive failure of both organs. This frequent pathophysiological condition has an extremely poor prognosis. Interactions between inflammation, the renin-angiotensin system, the balance between the nitric oxide and reactive oxygen species and the sympathetic nervous system form the cardiorenal connectors and are cornerstones in the pathophysiology of SCRS. An absolute deficit of erythropoietin (Epo) and decreased sensitivity to Epo in this syndrome both contribute to the development of anemia, which is more pronounced than renal anemia in the absence of heart failure. Besides expression on erythroid progenitor cells, Epo receptors are present in the heart, kidney, and vascular system, in which activation results in antiapoptosis, proliferation, and possibly antioxidation and anti-inflammation. Interestingly, Epo can improve cardiac and renal function. We have therefore reviewed the literature with respect to Epo and the cardiorenal connectors. Indeed, there are indications that Epo can diminish inflammation, reduce renin-angiotensin system activity, and shift the nitric oxide and reactive oxygen species balance toward nitric oxide. Information about Epo and the sympathetic nervous system is scarce. This analysis underscores the relevance of a further understanding of clinical and cellular mechanisms underlying protective effects of Epo, because this will support better treatment of SCRS.<\/jats:p>","DOI":"10.1152\/ajprenal.00200.2006","type":"journal-article","created":{"date-parts":[[2006,8,3]],"date-time":"2006-08-03T00:40:22Z","timestamp":1154565622000},"page":"F932-F944","source":"Crossref","is-referenced-by-count":65,"title":["Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors"],"prefix":"10.1152","volume":"291","author":[{"given":"Kim E.","family":"Jie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne C.","family":"Verhaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten-Jan M.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karien","family":"van der Putten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo A. J. M.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter A.","family":"Doevendans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein A.","family":"Koomans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap A.","family":"Joles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branko","family":"Braam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10787"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)03239-0"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.3.491"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00162.x"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80047-1"},{"key":"R6","unstructured":"Allen DA, Breen C, Yaqoob MM, and Macdougall IC.Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha.J Investig Med47: 204\u2013211, 1999."},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027361"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.15.5978"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.5.932"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00279.x"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00039.x"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90339-5"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816120-00007"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0744"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199906000-00007"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390903"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.37.22447"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-3-199408010-00004"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000118521.06245.b8"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi020"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00122.2003"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1159\/000179076"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.5414\/CPP41187"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0630444100"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.111"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00266.x"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.142"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.113"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00476.2002"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00277-4"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/23.15.3041"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1089\/152581602321080529"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200205000-00001"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1211\/0022357991772349"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2004.08.009"},{"key":"R36","unstructured":"Collins AJ.Anaemia management prior to dialysis: cardiovascular and cost-benefit observations.Nephrol Dial Transplant2: ii2\u2013ii6, 2003."},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(98)00101-5"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212313272704"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00697-2"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1002\/art.20875"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00784.x"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1177\/039139880402701105"},{"key":"R43","doi-asserted-by":"publisher","DOI":"10.1159\/000188510"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00608-7"},{"key":"R45","doi-asserted-by":"crossref","unstructured":"Ebert BLand Bunn HF.Regulation of the erythropoietin gene.Blood94: 1864\u20131877, 1999.","DOI":"10.1182\/blood.V94.6.1864"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1159\/000084109"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.11.101"},{"key":"R48","unstructured":"Erbayraktar S, Yilmaz O, Gokmen N, and Brines M.Erythropoietin is a multifunctional tissue-protective cytokine.Curr Hematol Rep2: 465\u2013470, 2003."},{"key":"R49","unstructured":"Fandrey Jand Bunn HF.In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction.Blood81: 617\u2013623, 1993."},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Faquin WC, Schneider TJ, and Goldberg MA.Effect of inflammatory cytokines on hypoxia-induced erythropoietin production.Blood79: 1987\u20131994, 1992.","DOI":"10.1182\/blood.V79.8.1987.bloodjournal7981987"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.9-90005-18"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.05.070"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(02)00934-7"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409329102"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00400.x"},{"key":"R56","doi-asserted-by":"publisher","DOI":"10.1007\/s004249900238"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1999.00530.x"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03753.x"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.06.022"},{"key":"R60","unstructured":"Ghiadoni L, Cupisti A, Huang Y, Mattei P, Cardinal H, Favilla S, Rindi P, Barsotti G, Taddei S, and Salvetti A.Endothelial dysfunction and oxidative stress in chronic renal failure.J Nephrol17: 512\u2013519, 2004."},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1995.075_c.x"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00084.x"},{"key":"R63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.142287899"},{"key":"R64","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.74.6.1141"},{"key":"R65","doi-asserted-by":"publisher","DOI":"10.1210\/me.2003-0231"},{"key":"R66","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/89.10.765"},{"key":"R67","unstructured":"Halliwell Band Gutteridge JMC.Free Radicals in Biology and Medicine. New York: Oxford Univ. Press, 1999."},{"key":"R68","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.354"},{"key":"R69","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590051960.x"},{"key":"R70","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0223"},{"key":"R71","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004050374"},{"key":"R72","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.2.203"},{"key":"R73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.11.4862"},{"key":"R74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2005.01526.x"},{"key":"R75","unstructured":"Horl WH, Jacobs C, Macdougall IC, Valderrabano F, Parrondo I, Thompson K, and Carveth BG.European best practice guidelines 14\u201316: inadequate response to epoetin.Nephrol Dial Transplant15,Suppl4: 43\u201350, 2000."},{"key":"R76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.13.9038"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2005.04.002"},{"key":"R78","doi-asserted-by":"publisher","DOI":"10.3109\/10641969509037420"},{"key":"R79","doi-asserted-by":"publisher","DOI":"10.1080\/10715769900300771"},{"key":"R80","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203829"},{"key":"R81","doi-asserted-by":"publisher","DOI":"10.1159\/000186138"},{"key":"R82","doi-asserted-by":"publisher","DOI":"10.1006\/mvre.2002.2426"},{"key":"R83","doi-asserted-by":"publisher","DOI":"10.1089\/107999002760274863"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1992.72.2.449"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.43.649"},{"key":"R86","doi-asserted-by":"publisher","DOI":"10.1007\/BFb0031014"},{"key":"R87","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.69"},{"key":"R88","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(92)90338-P"},{"key":"R89","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-3782(98)00030-9"},{"key":"R90","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200310000-00011"},{"key":"R91","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-003-0300-y"},{"key":"R92","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.7.743"},{"key":"R93","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27699"},{"key":"R94","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90351-8"},{"key":"R95","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.82.2.244"},{"key":"R96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1995.tb02354.x"},{"key":"R97","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000113320.57127.B9"},{"key":"R98","unstructured":"Ksiazek A, Zaluska WT, and Ksiazek P.Effect of recombinant human erythropoietin on adrenergic activity in normotensive hemodialysis patients.Clin Nephrol56: 104\u2013110, 2001."},{"key":"R99","doi-asserted-by":"crossref","unstructured":"Kumral A, Gonenc S, Acikgoz O, Sonmez A, Genc K, Yilmaz O, Gokmen N, Duman N, and Ozkan H.Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats.Biol Neonate87: 15\u201318, 2004.","DOI":"10.1159\/000080490"},{"key":"R100","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.4.346"},{"key":"R101","doi-asserted-by":"publisher","DOI":"10.1159\/000190270"},{"key":"R102","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.3.597"},{"key":"R103","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0168fje"},{"key":"R104","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2002.1101201.x"},{"key":"R105","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1995.268.4.R896"},{"key":"R106","unstructured":"Ludat K, Sommerburg O, Grune T, Siems WG, Riedel E, and Hampl H.Oxidation parameters in complete correction of renal anemia.Clin Nephrol53: S30\u201335, 2000."},{"key":"R107","doi-asserted-by":"crossref","unstructured":"Luo Gand Yu-Lee L.Stat5b inhibits NFkappaB-mediated signaling.Mol Endocrinol14: 114\u2013123, 2000.","DOI":"10.1210\/mend.14.1.0399"},{"key":"R108","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1060"},{"key":"R109","doi-asserted-by":"crossref","unstructured":"Macdougall ICand Cooper A.The inflammatory response and epoetin sensitivity.Nephrol Dial Transplant17, Suppl 1: 48\u201352, 2002.","DOI":"10.1093\/ndt\/17.suppl_1.48"},{"key":"R110","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.1.90"},{"key":"R111","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80049-5"},{"key":"R112","doi-asserted-by":"publisher","DOI":"10.1038\/375247a0"},{"key":"R113","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00887.x"},{"key":"R114","doi-asserted-by":"crossref","unstructured":"Maschio G.Erythropoietin and systemic hypertension.Nephrol Dial Transplant10,Suppl2: 74\u201379, 1995.","DOI":"10.1093\/ndt\/10.supp2.74"},{"key":"R115","doi-asserted-by":"crossref","unstructured":"Migliaccio AR, Jiang Y, Migliaccio G, Nicolis S, Crotta S, Ronchi A, Ottolenghi S, and Adamson JW.Transcriptional and posttranscriptional regulation of the expression of the erythropoietin receptor gene in human erythropoietin-responsive cell lines.Blood82: 3760\u20133769, 1993.","DOI":"10.1182\/blood.V82.12.3760.bloodjournal82123760"},{"key":"R116","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-120002663"},{"key":"R117","doi-asserted-by":"crossref","unstructured":"Miura Y, Miura O, Ihle JN, and Aoki N.Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor.J Biol Chem269: 29962\u201329969, 1994.","DOI":"10.1016\/S0021-9258(18)43975-0"},{"key":"R118","doi-asserted-by":"publisher","DOI":"10.1126\/science.2799385"},{"key":"R119","doi-asserted-by":"publisher","DOI":"10.1007\/BF01797612"},{"key":"R120","doi-asserted-by":"crossref","unstructured":"Muntner P, He J, Hamm L, Loria C, and Whelton PK.Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.J Am Soc Nephrol13: 745\u2013753, 2002.","DOI":"10.1681\/ASN.V133745"},{"key":"R121","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/27.7.1233"},{"key":"R122","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1838(91)90042-2"},{"key":"R123","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004999200"},{"key":"R124","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.19.91"},{"key":"R125","unstructured":"Ono Kand Hisasue Y.The rate of increase in hematocrit, humoral vasoactive substances and blood pressure changes in hemodialysis patients treated with recombinant human erythropoietin or blood transfusion.Clin Nephrol37: 23\u201327, 1992."},{"key":"R126","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/6.8.562"},{"key":"R127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00399.x"},{"key":"R128","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M314099200"},{"key":"R129","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18200"},{"key":"R130","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90335-8"},{"key":"R131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb05644.x"},{"key":"R132","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.3.645"},{"key":"R133","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03058.x"},{"key":"R134","doi-asserted-by":"crossref","unstructured":"Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell\u2019Era P, Nico B, Roncali L, and Dammacco F.Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.Blood93: 2627\u20132636, 1999.","DOI":"10.1182\/blood.V93.8.2627.408k21_2627_2636"},{"key":"R135","doi-asserted-by":"publisher","DOI":"10.1016\/0094-5765(94)90118-X"},{"key":"R136","unstructured":"Roger SD, Baker LR, and Raine AE.Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).Clin Nephrol39: 103\u2013110, 1993."},{"key":"R137","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.11.019"},{"key":"R138","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00089.x"},{"key":"R139","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00400.x"},{"key":"R140","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004090735"},{"key":"R141","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.12.1195"},{"key":"R142","doi-asserted-by":"publisher","DOI":"10.1177\/039139889201500605"},{"key":"R143","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.17.12848"},{"key":"R144","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90128-7"},{"key":"R145","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2005.01530.x"},{"key":"R146","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb03399.x"},{"key":"R147","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000135059.67385.5D"},{"key":"R148","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204383"},{"key":"R149","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.32.22165"},{"key":"R150","doi-asserted-by":"crossref","unstructured":"Silva M, Grillot D, Benito A, Richard C, Nunez G, and Fernandez-Luna JL.Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2.Blood88: 1576\u20131582, 1996.","DOI":"10.1182\/blood.V88.5.1576.bloodjournal8851576"},{"key":"R151","doi-asserted-by":"crossref","unstructured":"Silverberg D, Wexler D, Blum M, Wollman Y, and Iaina A.The cardio-renal anaemia syndrome: does it exist?Nephrol Dial Transplant18,Suppl8: viii7\u2013viii12, 2003.","DOI":"10.1093\/ndt\/gfg1084"},{"key":"R152","unstructured":"Silverberg DS, Wexler D, Blum M, and Iaina A.The cardiorenal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations.Clin Nephrol60,Suppl1: S93\u2013S102, 2003."},{"key":"R153","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00613-6"},{"key":"R154","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01248-7"},{"key":"R155","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051606598"},{"key":"R156","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.8.1207"},{"key":"R157","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(03)00468-1"},{"key":"R158","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3261"},{"key":"R159","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M506008200"},{"key":"R160","doi-asserted-by":"publisher","DOI":"10.1159\/000045606"},{"key":"R161","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000145436.09176.A7"},{"key":"R162","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2240"},{"key":"R163","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9767"},{"key":"R164","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90865-Z"},{"key":"R165","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.03.052"},{"key":"R166","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70413-0"},{"key":"R167","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1998.274.2.H642"},{"key":"R168","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1994.266.3.F360"},{"key":"R169","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1996.271.1.E113"},{"key":"R170","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg547"},{"key":"R171","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021067"},{"key":"R172","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199606)167:3<461::AID-JCP10>3.0.CO;2-7"},{"key":"R173","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.33.3.894"},{"key":"R174","doi-asserted-by":"crossref","unstructured":"Warren DJand Ferris TF.Renin secretion in renal hypertension.Lancet1: 159\u2013162, 1970.","DOI":"10.1016\/S0140-6736(70)90404-6"},{"key":"R175","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.055003808.x"},{"key":"R176","doi-asserted-by":"crossref","unstructured":"Wickrema A, Krantz SB, Winkelmann JC, and Bondurant MC.Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells.Blood80: 1940\u20131949, 1992.","DOI":"10.1182\/blood.V80.8.1940.1940"},{"key":"R177","doi-asserted-by":"crossref","unstructured":"Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drueke T, and Descamps-Latscha B.Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.J Immunol161: 2524\u20132532, 1998.","DOI":"10.4049\/jimmunol.161.5.2524"},{"key":"R178","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-1289fje"},{"key":"R179","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-1191fje"},{"key":"R180","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.2.475"},{"key":"R181","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-22-09821.1999"},{"key":"R182","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1007"},{"key":"R183","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb44683.x"}],"container-title":["American Journal of Physiology-Renal Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajprenal.00200.2006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T11:37:04Z","timestamp":1683545824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajprenal.00200.2006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":183,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1152\/ajprenal.00200.2006"],"URL":"https:\/\/doi.org\/10.1152\/ajprenal.00200.2006","relation":{},"ISSN":["1931-857X","1522-1466"],"issn-type":[{"value":"1931-857X","type":"print"},{"value":"1522-1466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}